The Center to Advance Palliative Care's definition states, "Palliative care is specialized medical care for people with serious illnesses. This type of care is focused on providing patients with relief from the symptoms, pain, and stress of a serious illness—whatever the diagnosis. The goal is to improve quality of life for both the patient and the family. Palliative care is provided by a team of doctors, nurses, and other specialists who work with a patient's other doctors to provide an extra layer of support. Palliative care is appropriate at any age and at any stage in a serious illness, and can be provided together with curative treatment."

Palliative care includes management of physical symptoms, such as pain, dyspnea, nausea and vomiting, constipation, delirium, and agitation; emotional distress, such as depression, anxiety, and interpersonal strain; and existential distress, such as spiritual crisis. While palliative care is a medical subspecialty recognized by the American Board of Medical Specialties and governing bodies around the world (“specialty palliative care”) and is typically provided by an interdisciplinary team of experts, all clinicians should have the skills to provide “primary palliative care” including managing pain; treating dyspnea; identifying mood disorders; communicating about prognosis and patient preferences for care; and helping address spiritual distress. Advanced certification in palliative care for healthcare organizations is offered by The Joint Commission, and the World Health Organization has adopted a resolution calling for the integration of palliative care services into the structure and financing of national healthcare systems.

During any stage of illness, patients should be screened routinely for symptoms. Any symptoms that cause significant suffering are a medical emergency that should be managed aggressively with frequent elicitation and reassessment as well as individualized treatment. While patients at the end of life may experience a host of distressing symptoms, pain, dyspnea, and delirium are among the most feared and burdensome. Management of these common symptoms is described later in this chapter. The principles of palliative care dictate that properly informed patients or their surrogates may decide to pursue aggressive symptom relief at the end of life even if, as a known but unintended consequence, the treatments hasten death. Randomized studies have shown that palliative care provided alongside disease-focused treatment can improve quality of life, promote symptom management, and even prolong life.

Basch  E  et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017 Jul 11;318(2):197–8. 
[PubMed: 28586821] 
CrossRef
El-Jawahri  A  et al. Effect of inpatient palliative care during hematopoietic stem-cell transplant on psychological distress 6 months after transplant: results of a randomized clinical trial. J Clin Oncol. 2017 Nov 10;35(32):3714–21. 
[PubMed: 28926288] 
CrossRef
Epstein  RM  et al. A piece of my mind. Responding to suffering. JAMA. 2015 Dec 22–29;314(24):2623–4. 
[PubMed: 26720023] 
CrossRef
Ferrell  BR  et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017 Jan;35(1):96–112. 
[PubMed: 28034065] 
CrossRef
Gaertner  J  et al. Effect of specialist palliative care services on quality of life in adults with advanced incurable illness in hospital, hospice, or community settings: systematic review and meta-analysis. BMJ. 2017 Jul 4;357:j2925. 
[PubMed: 28676557] 
CrossRef
Haun  MW  et al. Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev. 2017 Jun 12;6:CD011129. 
[PubMed: 28603881] 
Institute of Medicine. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. National Academies Press; 2015 Mar 19. 
[PubMed: 25927121] 
Kavalieratos  D  et al. Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA. 2016 Nov 22;316(20):2104–14. 
[PubMed: 27893131] 
CrossRef
Rabow  M  et al. Moving upstream: a review of the evidence of the impact of outpatient palliative care. J Palliat Med. 2013 Dec;16(12):1540–9. 
[PubMed: 24225013] 
CrossRef
Temel  JS  et al. Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol. 2017 Mar 10;35(8):834–41. 
[PubMed: 28029308] 
CrossRef

PALLIATION OF COMMON NONPAIN SYMPTOMS

DYSPNEA

Dyspnea is the subjective experience of difficulty breathing and may be characterized by patients as tightness in the chest, shortness of breath, breathlessness, or a feeling of suffocation. Up to half of people at the end of life may experience severe dyspnea.

Treatment of dyspnea is usually first directed at the cause (see Chapter 9). At the end of life, dyspnea is often treated nonspecifically with opioids, which are the single best class of medications for dyspnea with demonstrated effectiveness in multiple randomized trials. Starting doses are typically lower than would be necessary for the relief of moderate pain. Immediate-release morphine given orally (2–4 mg every 4 hours) or intravenously (1–2 mg every 4 hours) treats dyspnea effectively. Sustained-release morphine given orally at 10 mg daily is safe and effective for most patients with ongoing dyspnea. Supplemental oxygen may be useful for the dyspneic patient who is hypoxic. However, a nasal cannula and face mask are sometimes not well tolerated, and fresh air from a window or fan may provide relief for patients who are not hypoxic. Judicious use of noninvasive ventilation as well as nonpharmacologic relaxation techniques, such as meditation and guided imagery, may be beneficial for some patients. Benzodiazepines may be useful adjuncts for treatment of dyspnea-related anxiety.

NAUSEA & VOMITING

Nausea and vomiting are common and distressing symptoms. As with pain, the management of nausea may be optimized by regular dosing and often requires multiple medications. An understanding of the four major inputs to the vomiting center may help direct treatment (see Chapter 15).

Vomiting associated with opioids is discussed below. Nasogastric suction may provide rapid, short-term relief for vomiting associated with constipation (in addition to laxatives), gastroparesis, or gastric outlet or bowel obstruction. Prokinetic agents, such as metoclopramide (5–20 mg orally or intravenously four times a day) or domperidone (not available in the United States), can be helpful in the setting of partial gastric outlet obstruction. Transdermal scopolamine (1.5-mg patch every 3 days) can reduce peristalsis and cramping pain, and ranitidine (50 mg intravenously every 6 hours) can reduce gastric secretions. Octreotide (starting at 50–100 mcg subcutaneously every 8 hours or as continuous intravenous or subcutaneous infusion, beginning at 10–20 mcg/h) can reduce gastric secretions and may have a role in relieving nausea and vomiting from malignant bowel obstruction. High-dose corticosteroids (eg, dexamethasone, 20 mg orally or intravenously daily in divided doses) can be used in refractory cases of nausea or vomiting or when it is due to bowel obstruction or increased intracranial pressure.

Vomiting due to disturbance of the vestibular apparatus may be treated with anticholinergic and antihistaminic agents (including diphenhydramine, 25 mg orally or intravenously every 8 hours, or scopolamine, 1.5-mg patch every 3 days).

Benzodiazepines (eg, lorazepam, 0.5–1.0 mg given orally every 6–8 hours) can be effective in preventing the anticipatory nausea associated with chemotherapy. For emetogenic chemotherapy, therapy includes combinations of 5-HT3-antagonists (eg, ondansetron, granisetron, dolasetron, or palonosetron), neurokinin-1 receptor antagonists (eg, aprepitant, fosaprepitant, or rolapitant), the N-receptor antagonist netupitant combined with palonosetron (NEPA), olanzapinedexamethasone, and prochlorperazine. In addition to its effect on mood, mirtazepine, 15–45 mg orally nightly may help with nausea and improve appetite. Finally, dronabinol (2.5–20 mg orally every 4–6 hours) can be helpful in the management of nausea and vomiting. Some patients report relief from medical cannabis.

CONSTIPATION

Given the frequent use of opioids, poor dietary intake, physical inactivity, and lack of privacy, constipation is a common problem in seriously ill and dying patients. Clinicians must inquire about any difficulty with hard or infrequent stools. Constipation is an easily preventable and treatable cause of discomfort, distress, and nausea and vomiting (see Chapter 15).

Constipation may be prevented or relieved if patients can increase their activity and their intake of fluids. Simple considerations, such as privacy, undisturbed toilet time, and a bedside commode rather than a bedpan may be important for some patients.

A prophylactic bowel regimen with a stimulant laxative (senna or bisacodyl) should be started when opioid treatment is begun. Table 15–4 lists other agents (including osmotic laxatives such as polyethylene glycol) that can be added as needed. Docusate, a stool softener, is not recommended. Naloxegol, an oral peripherally acting receptor antagonist, and lubiprostone are FDA approved to treat opioid-induced constipation in patients with chronic noncancer pain. Methylnaltrexone, a subcutaneous medication, is a peripherally acting mu-receptor antagonist and is available for severe, unrelieved, opioid-induced constipation. Patients who report being constipated and then have diarrhea typically are passing liquid stool around impacted stool. Patients with this series of events should have a rectal examination to assess for impaction; if it is present, disimpaction will be required.

FATIGUE

Fatigue is a distressing symptom and is the most common complaint among cancer patients. Specific abnormalities that can contribute to fatigue, including anemia, hypothyroidism, hypogonadism, cognitive and functional impairment, and malnutrition, should be corrected. Because pain, depression, and fatigue often coexist in patients with cancer, pain and depression should be managed appropriately in patients with fatigue. Fatigue from medication adverse effects and polypharmacy is common and should be addressed. For nonspecific fatigue, exercise and physical rehabilitation may be most effective. Although commonly used, strong evidence for psychostimulants, such as methylphenidate, 5–10 mg orally in the morning and afternoon, or modafinil, 200 mg orally in the morning, for cancer-related fatigue is lacking. American Ginseng (Panax quinquefolius) has been shown to be effective for cancer-related fatigue but may have an estrogenic effect. Corticosteroids may have a short-term benefit. Caffeinated beverages can help(eg, have been shown to increase exercise tolerance in patients with heart failure).

DELIRIUM & AGITATION

Many patients die in a state of delirium—a waxing and waning in level of consciousness and a change in cognition that develops over a short time and is manifested by misinterpretations, illusions, hallucinations, sleep-wake cycle disruptions, psychomotor disturbances (eg, lethargy, restlessness), and mood disturbances (eg, fear, anxiety). Delirium may be hyperactive, hypoactive, or mixed. Hypoactive delirium may be difficult to distinguish from active dying. Agitated delirium at the end of life has been called terminal restlessness.

Some delirious patients may be “pleasantly confused,” although it is difficult to know what patients experience. In the absence of obvious distress in the patient, a decision by the patient’s family and the clinician not to treat delirium may be considered. More commonly, however, agitated delirium at the end of life is distressing to patients and family and requires treatment. Delirium may interfere with the family’s ability to interact with or feel comforting to the patient and may prevent a patient from being able to recognize and report important symptoms. Reversible causes of delirium include urinary retention, constipation, anticholinergic medications, and pain; these should be addressed whenever possible. There is no evidence that hydration relieves or dehydration causes delirium. Careful attention to patient safety and nonpharmacologic strategies to help the patient remain oriented (clock, calendar, familiar environment, reassurance and redirection from caregivers) may be sufficient to prevent or manage mild delirium. A randomized trial of placebo compared to risperidone or haloperidol in delirious patients demonstrated increased mortality with neuroleptics. Thus, the benefits of neuroleptic agents (eg, haloperidol, 1–10 mg orally, subcutaneously, intramuscularly, or intravenously twice or three times a day, or risperidone, 1–3 mg orally twice a day) in the treatment of agitated delirium must be weighed carefully against their potential harms. Ramelteon, a melatonin agonist, at 8 mg/day orally has been shown to prevent delirium in seriously ill, older hospitalized patients. It should be avoided in patients with severe liver disease. When delirium is refractory to treatment and remains intolerable, sedation may be required to provide relief. Sedation may be achieved rapidly with midazolam (0.5–5 mg/h subcutaneously or intravenously) or barbiturates.

Agar  MR  et al. Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Intern Med. 2017 Jan 1;177(1):34–42. 
[PubMed: 27918778] 
CrossRef
Currow  DC  et al. Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. J Pain Symptom Manage. 2015 May;49(5):814–21. 
[PubMed: 25462210] 
CrossRef
Hui  D  et al. Effect of lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care: a randomized clinical trial. JAMA. 2017 Sep 19;318(11):1047–56. 
[PubMed: 28975307] 
CrossRef
Mitchell  GK  et al. The effect of methylphenidate on fatigue in advanced cancer: an aggregated N-of-1 trial. J Pain Symptom Manage. 2015 Sep;50(3):289–96. 
[PubMed: 25896104] 
CrossRef
Singer  AE  et al. Symptom trends in the last year of life from 1998 to 2010: a cohort study. Ann Intern Med. 2015 Feb 3;162(3):175–83. 
[PubMed: 25643305] 
CrossRef

 

Update December 29, 2025


Palliative care is medical care focused on improving quality of life for people living with serious illness. Palliative care addresses and treats symptoms, supports patients’ families and loved ones, and helps ensure that care aligns with patients’ preferences, values, and goals. Near the end of life, palliative care may become the sole focus of care, but palliative care alongside cure-focused treatment or disease management is beneficial throughout the course of a serious illness, regardless of its prognosis.

The Center to Advance Palliative Care's definition states, "Palliative care is specialized medical care for people with serious illnesses. This type of care is focused on providing patients with relief from the symptoms, pain, and stress of a serious illness—whatever the diagnosis. The goal is to improve quality of life for both the patient and the family. Palliative care is provided by a team of doctors, nurses, and other specialists who work with a patient's other doctors to provide an extra layer of support. Palliative care is appropriate at any age and at any stage in a serious illness, and can be provided together with curative treatment."

Palliative care includes management of physical symptoms, such as pain, dyspnea, nausea and vomiting, constipation, delirium, and agitation; emotional distress, such as depression, anxiety, and interpersonal strain; and existential distress, such as spiritual crisis. While palliative care is a medical subspecialty recognized by the American Board of Medical Specialties and governing bodies around the world (“specialty palliative care”) and is typically provided by an interdisciplinary team of experts, all clinicians should have the skills to provide “primary palliative care” including managing pain; treating dyspnea; identifying mood disorders; communicating about prognosis and patient preferences for care; and helping address spiritual distress. Advanced certification in palliative care for healthcare organizations is offered by The Joint Commission, and the World Health Organization has adopted a resolution calling for the integration of palliative care services into the structure and financing of national healthcare systems.

During any stage of illness, patients should be screened routinely for symptoms. Any symptoms that cause significant suffering are a medical emergency that should be managed aggressively with frequent elicitation and reassessment as well as individualized treatment. While patients at the end of life may experience a host of distressing symptoms, pain, dyspnea, and delirium are among the most feared and burdensome. Management of these common symptoms is described later in this chapter. The principles of palliative care dictate that properly informed patients or their surrogates may decide to pursue aggressive symptom relief at the end of life even if, as a known but unintended consequence, the treatments hasten death. Randomized studies have shown that palliative care provided alongside disease-focused treatment can improve quality of life, promote symptom management, and even prolong life.

Basch  E  et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017 Jul 11;318(2):197–8. 
[PubMed: 28586821] 
CrossRef
El-Jawahri  A  et al. Effect of inpatient palliative care during hematopoietic stem-cell transplant on psychological distress 6 months after transplant: results of a randomized clinical trial. J Clin Oncol. 2017 Nov 10;35(32):3714–21. 
[PubMed: 28926288] 
CrossRef
Epstein  RM  et al. A piece of my mind. Responding to suffering. JAMA. 2015 Dec 22–29;314(24):2623–4. 
[PubMed: 26720023] 
CrossRef
Ferrell  BR  et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017 Jan;35(1):96–112. 
[PubMed: 28034065] 
CrossRef
Gaertner  J  et al. Effect of specialist palliative care services on quality of life in adults with advanced incurable illness in hospital, hospice, or community settings: systematic review and meta-analysis. BMJ. 2017 Jul 4;357:j2925. 
[PubMed: 28676557] 
CrossRef
Haun  MW  et al. Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev. 2017 Jun 12;6:CD011129. 
[PubMed: 28603881] 
Institute of Medicine. Dying in America: Improving Quality and Honoring Individual Preferences Near the End of Life. National Academies Press; 2015 Mar 19. 
[PubMed: 25927121] 
Kavalieratos  D  et al. Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA. 2016 Nov 22;316(20):2104–14. 
[PubMed: 27893131] 
CrossRef
Rabow  M  et al. Moving upstream: a review of the evidence of the impact of outpatient palliative care. J Palliat Med. 2013 Dec;16(12):1540–9. 
[PubMed: 24225013] 
CrossRef
Temel  JS  et al. Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. J Clin Oncol. 2017 Mar 10;35(8):834–41. 
[PubMed: 28029308] 
CrossRef

PALLIATION OF COMMON NONPAIN SYMPTOMS

DYSPNEA

Dyspnea is the subjective experience of difficulty breathing and may be characterized by patients as tightness in the chest, shortness of breath, breathlessness, or a feeling of suffocation. Up to half of people at the end of life may experience severe dyspnea.

Treatment of dyspnea is usually first directed at the cause (see Chapter 9). At the end of life, dyspnea is often treated nonspecifically with opioids, which are the single best class of medications for dyspnea with demonstrated effectiveness in multiple randomized trials. Starting doses are typically lower than would be necessary for the relief of moderate pain. Immediate-release morphine given orally (2–4 mg every 4 hours) or intravenously (1–2 mg every 4 hours) treats dyspnea effectively. Sustained-release morphine given orally at 10 mg daily is safe and effective for most patients with ongoing dyspnea. Supplemental oxygen may be useful for the dyspneic patient who is hypoxic. However, a nasal cannula and face mask are sometimes not well tolerated, and fresh air from a window or fan may provide relief for patients who are not hypoxic. Judicious use of noninvasive ventilation as well as nonpharmacologic relaxation techniques, such as meditation and guided imagery, may be beneficial for some patients. Benzodiazepines may be useful adjuncts for treatment of dyspnea-related anxiety.

NAUSEA & VOMITING

Nausea and vomiting are common and distressing symptoms. As with pain, the management of nausea may be optimized by regular dosing and often requires multiple medications. An understanding of the four major inputs to the vomiting center may help direct treatment (see Chapter 15).

Vomiting associated with opioids is discussed below. Nasogastric suction may provide rapid, short-term relief for vomiting associated with constipation (in addition to laxatives), gastroparesis, or gastric outlet or bowel obstruction. Prokinetic agents, such as metoclopramide (5–20 mg orally or intravenously four times a day) or domperidone (not available in the United States), can be helpful in the setting of partial gastric outlet obstruction. Transdermal scopolamine (1.5-mg patch every 3 days) can reduce peristalsis and cramping pain, and ranitidine (50 mg intravenously every 6 hours) can reduce gastric secretions. Octreotide (starting at 50–100 mcg subcutaneously every 8 hours or as continuous intravenous or subcutaneous infusion, beginning at 10–20 mcg/h) can reduce gastric secretions and may have a role in relieving nausea and vomiting from malignant bowel obstruction. High-dose corticosteroids (eg, dexamethasone, 20 mg orally or intravenously daily in divided doses) can be used in refractory cases of nausea or vomiting or when it is due to bowel obstruction or increased intracranial pressure.

Vomiting due to disturbance of the vestibular apparatus may be treated with anticholinergic and antihistaminic agents (including diphenhydramine, 25 mg orally or intravenously every 8 hours, or scopolamine, 1.5-mg patch every 3 days).

Benzodiazepines (eg, lorazepam, 0.5–1.0 mg given orally every 6–8 hours) can be effective in preventing the anticipatory nausea associated with chemotherapy. For emetogenic chemotherapy, therapy includes combinations of 5-HT3-antagonists (eg, ondansetron, granisetron, dolasetron, or palonosetron), neurokinin-1 receptor antagonists (eg, aprepitant, fosaprepitant, or rolapitant), the N-receptor antagonist netupitant combined with palonosetron (NEPA), olanzapinedexamethasone, and prochlorperazine. In addition to its effect on mood, mirtazepine, 15–45 mg orally nightly may help with nausea and improve appetite. Finally, dronabinol (2.5–20 mg orally every 4–6 hours) can be helpful in the management of nausea and vomiting. Some patients report relief from medical cannabis.

CONSTIPATION

Given the frequent use of opioids, poor dietary intake, physical inactivity, and lack of privacy, constipation is a common problem in seriously ill and dying patients. Clinicians must inquire about any difficulty with hard or infrequent stools. Constipation is an easily preventable and treatable cause of discomfort, distress, and nausea and vomiting (see Chapter 15).

Constipation may be prevented or relieved if patients can increase their activity and their intake of fluids. Simple considerations, such as privacy, undisturbed toilet time, and a bedside commode rather than a bedpan may be important for some patients.

A prophylactic bowel regimen with a stimulant laxative (senna or bisacodyl) should be started when opioid treatment is begun. Table 15–4 lists other agents (including osmotic laxatives such as polyethylene glycol) that can be added as needed. Docusate, a stool softener, is not recommended. Naloxegol, an oral peripherally acting receptor antagonist, and lubiprostone are FDA approved to treat opioid-induced constipation in patients with chronic noncancer pain. Methylnaltrexone, a subcutaneous medication, is a peripherally acting mu-receptor antagonist and is available for severe, unrelieved, opioid-induced constipation. Patients who report being constipated and then have diarrhea typically are passing liquid stool around impacted stool. Patients with this series of events should have a rectal examination to assess for impaction; if it is present, disimpaction will be required.

FATIGUE

Fatigue is a distressing symptom and is the most common complaint among cancer patients. Specific abnormalities that can contribute to fatigue, including anemia, hypothyroidism, hypogonadism, cognitive and functional impairment, and malnutrition, should be corrected. Because pain, depression, and fatigue often coexist in patients with cancer, pain and depression should be managed appropriately in patients with fatigue. Fatigue from medication adverse effects and polypharmacy is common and should be addressed. For nonspecific fatigue, exercise and physical rehabilitation may be most effective. Although commonly used, strong evidence for psychostimulants, such as methylphenidate, 5–10 mg orally in the morning and afternoon, or modafinil, 200 mg orally in the morning, for cancer-related fatigue is lacking. American Ginseng (Panax quinquefolius) has been shown to be effective for cancer-related fatigue but may have an estrogenic effect. Corticosteroids may have a short-term benefit. Caffeinated beverages can help(eg, have been shown to increase exercise tolerance in patients with heart failure).

DELIRIUM & AGITATION

Many patients die in a state of delirium—a waxing and waning in level of consciousness and a change in cognition that develops over a short time and is manifested by misinterpretations, illusions, hallucinations, sleep-wake cycle disruptions, psychomotor disturbances (eg, lethargy, restlessness), and mood disturbances (eg, fear, anxiety). Delirium may be hyperactive, hypoactive, or mixed. Hypoactive delirium may be difficult to distinguish from active dying. Agitated delirium at the end of life has been called terminal restlessness.

Some delirious patients may be “pleasantly confused,” although it is difficult to know what patients experience. In the absence of obvious distress in the patient, a decision by the patient’s family and the clinician not to treat delirium may be considered. More commonly, however, agitated delirium at the end of life is distressing to patients and family and requires treatment. Delirium may interfere with the family’s ability to interact with or feel comforting to the patient and may prevent a patient from being able to recognize and report important symptoms. Reversible causes of delirium include urinary retention, constipation, anticholinergic medications, and pain; these should be addressed whenever possible. There is no evidence that hydration relieves or dehydration causes delirium. Careful attention to patient safety and nonpharmacologic strategies to help the patient remain oriented (clock, calendar, familiar environment, reassurance and redirection from caregivers) may be sufficient to prevent or manage mild delirium. A randomized trial of placebo compared to risperidone or haloperidol in delirious patients demonstrated increased mortality with neuroleptics. Thus, the benefits of neuroleptic agents (eg, haloperidol, 1–10 mg orally, subcutaneously, intramuscularly, or intravenously twice or three times a day, or risperidone, 1–3 mg orally twice a day) in the treatment of agitated delirium must be weighed carefully against their potential harms. Ramelteon, a melatonin agonist, at 8 mg/day orally has been shown to prevent delirium in seriously ill, older hospitalized patients. It should be avoided in patients with severe liver disease. When delirium is refractory to treatment and remains intolerable, sedation may be required to provide relief. Sedation may be achieved rapidly with midazolam (0.5–5 mg/h subcutaneously or intravenously) or barbiturates.

Agar  MR  et al. Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Intern Med. 2017 Jan 1;177(1):34–42. 
[PubMed: 27918778] 
CrossRef
Currow  DC  et al. Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. J Pain Symptom Manage. 2015 May;49(5):814–21. 
[PubMed: 25462210] 
CrossRef
Hui  D  et al. Effect of lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care: a randomized clinical trial. JAMA. 2017 Sep 19;318(11):1047–56. 
[PubMed: 28975307] 
CrossRef
Mitchell  GK  et al. The effect of methylphenidate on fatigue in advanced cancer: an aggregated N-of-1 trial. J Pain Symptom Manage. 2015 Sep;50(3):289–96. 
[PubMed: 25896104] 
CrossRef
Singer  AE  et al. Symptom trends in the last year of life from 1998 to 2010: a cohort study. Ann Intern Med. 2015 Feb 3;162(3):175–83. 
[PubMed: 25643305] 
CrossRef

+++++++++++++++++

https://www.practicalpainmanagement.com/resources/hospice/pain-management-terminal-illness

+++++++++++++++++

Counsel and comfort dying patients and their significant others. Critical care physicians often must redirect the goals of care from resuscitation and cure to comfort.

 

Palliative care at the end of life focuses on relieving distressing symptoms.

Communication and Clarification of Goals

Clinicians help patients understand when they are approaching the end of life.

Physicians help patients and caregivers understand the course of disease or recognize when death is imminent. When possible, a range of likely survival durations should be given, perhaps advising people to "hope for the best but plan for the worst." Educating patients early provides them time to address spiritual and psychosocial concerns and to deliberate and make reasoned decisions about priorities for their care and their estate. Priorities can differ when facing death. For example, some people value prolongation of life, even if it causes discomfort, costs money, or burdens family. Other people identify specific goals, such as maintaining function and independence, or relieving symptoms, such as pain. Some people are most concerned with seeking forgiveness, reconciling, or providing for a loved one.

Advance care plans should be documented and readily accessible to other health care providers (eg, emergency department) to offer the best chance of achieving the patient's desired care. State-authorized Physician Orders for Life-Sustaining Treatment (POLST) and similar programs are widely used and should be easily accessible in the home and in the medical record to direct emergency medical personnel regarding what medical care to give and to forgo. Decisions about specific treatments can be helpful. For example, cardiopulmonary resuscitation and transport to a hospital are usually not desirable if death is imminent; in contrast, certain aggressive treatments (eg, blood transfusions, chemotherapy) may be desired to relieve symptoms even if death is expected within days.

]

 

To inform or not to inform depends on individual and family preference.

Most patients (and their family caregivers) want accurate prognostic information. This information influences patients’ treatment decisions, may change how they spend their remaining time, and does not negatively impact patient survival. One-half or more of cancer patients do not understand that many treatments they might be offered are palliative and not curative. Patients require support for any distress that may accompany discussions of prognostic information.

While certain diseases, such as cancer, are more amenable to prognostic estimates regarding the time course to death, the other common causes of mortality—including heart disease, stroke, chronic lung disease, and dementia—have more variable trajectories and difficult-to-predict prognoses. Even for patients with cancer, clinician estimates of prognosis are often inaccurate and generally overly optimistic. Nonetheless, clinical experience, epidemiologic data, guidelines from professional organizations, and computer modeling and prediction tools (eg, the Palliative Performance Scale or http://eprognosis.ucsf.edu/index.php) may be used to help offer patients more realistic estimates of prognosis. Clinicians can also ask themselves “Would I be surprised if this patient died in the next year?” to determine whether a discussion of prognosis would be appropriate. If the answer is “no,” then the clinician should initiate a discussion. Recognizing that patients may have different levels of comfort with prognostic information, clinicians can introduce the topic by simply saying, “I have information about the likely time course of your illness. Would you like to talk about it?”

EXPECTATIONS ABOUT THE END OF LIFE

Patients' experiences at the end of life are influenced by their expectations about how they will die and the meaning of death. Many people fear how they will die more than death itself. Patients report fears of dying in pain or of suffocation, of loss of control, of indignity, of isolation, and of being a burden to their families. All of these anxieties may be ameliorated with good supportive care provided by an attentive group of caretakers.

Death is often regarded by clinicians, patients, and families as a failure of medical science. This attitude can create or heighten a sense of guilt about the failure to prevent dying. Both the general public and clinicians often view death as an enemy to be battled furiously in hospitals rather than as an inevitable outcome to be experienced as a part of life at home. As a result, approximately 75% of people in the United States die in hospitals or long-term care facilities.

Even when the clinician and patient continue to pursue cure of potentially reversible disease, relieving suffering, providing support, and helping the patient make the most of their life should be foremost considerations. Patients at the end of life and their families identify a number of elements as important to quality end-of-life care: managing pain and other symptoms adequately, avoiding inappropriate prolongation of dying, communicating clearly, preserving dignity, preparing for death, achieving a sense of control, relieving the burden on others, and strengthening relationships with loved ones.

COMMUNICATION & CARE OF THE PATIENT

Caring for patients at the end of life requires the same skills clinicians use in other tasks of medical care: diagnosing treatable conditions, providing patient education, facilitating decision making, and expressing understanding and caring. Communication skills are vitally important and can be improved through training. Higher-quality communication is associated with greater satisfaction and awareness of patient wishes. Clinicians must become proficient at delivering serious news and then dealing with its consequences (Table 5–1). Smartphone and Internet communication resources are available to support clinicians (www.vitaltalk.org), and evidence suggests that communication checklists or guides can be effective. When the clinician and patient do not share a common language, the use of a professional interpreter is needed to facilitate clear communication and help broker cultural issues.

++++++++++++++++++++++++++++++++++++++++

The focus of end of life care is comfort. This palliative or hospice care.

Palliative care addresses and treats symptoms and supports patients’ families and loved ones

The care of the dying:

is compassionate

is based on and tailored to the needs, wishes and preferences of the dying person and, as appropriate, their family and those identified as important to them

includes regular and effective communication between the dying person and their family and health and care staff and between health and care staff themselves

involves assessment of the person's condition whenever that condition changes and timely and appropriate responses to those changes

is led by a senior responsible doctor and a lead responsible nurse, who can access support from specialist palliative care services

 

 

 

Treatment of Symptoms

What blood level of morphine is the most appropriate when treating pain from a terminal cause?

Next Question
You will be able to view all answers at the end of your quiz.

The correct answer is D. You answered D.

The correct answer is "D." There is no consistent relationship between blood levels of morphine and analgesic effects. This is because of tolerance, individual variability in drug effect, etc. Thus, there is no single "right" dose. You should titrate morphine to the desired effect while watching for side effects. See question 27.2.4: Helpful Tip.

Constipation
FREQUENCY

Constipation is reported in up to 87% of patients requiring palliative care.

ETIOLOGY

Constipation is most frequently a predictable consequence of the use of opioids for the relief of pain and dyspnea and of tricyclic antidepressants, from their anticholinergic effects, and of the inactivity and poor diet that are common among seriously ill patients. If untreated, constipation can cause substantial pain and vomiting and also is associated with confusion and delirium. Whenever opioids and other medications known to cause constipation are used, preemptive treatment for constipation should be instituted.

Although hypercalcemia and other factors can cause constipation,
ASSESSMENT

The physician should establish the patient’s previous bowel habits, including the frequency, consistency, and volume. Abdominal and rectal examinations should be performed to exclude impaction or acute abdomen. A number of constipation assessment scales are available, although guidelines issued in the Journal of Palliative Medicine did not recommend them for routine practice. Radiographic assessments beyond a simple flat plate of the abdomen in cases in which obstruction is suspected are rarely necessary.

INTERVENTION

Intervention to reestablish comfortable bowel habits and relieve pain and discomfort should be the goals of any measures to address constipation during end-of-life care. Although physical activity, adequate hydration, and dietary treatments with fiber can be helpful, each is limited in its effectiveness for most seriously ill patients, and fiber may exacerbate problems in the setting of dehydration and if impaired motility is the etiology. Fiber is contraindicated in the presence of opioid use. Stimulant and osmotic laxatives, stool softeners, fluids, and enemas are the mainstays of therapy (Table 10-5). In preventing constipation from opioids and other medications, a combination of a laxative and a stool softener (such as senna and docusate) should be used. If after several days of treatment, a bowel movement has not occurred, a rectal examination to remove impacted stool and place a suppository is necessary. For patients with impending bowel obstruction or gastric stasis, octreotide to reduce secretions can be helpful. For patients in whom the suspected mechanism is dysmotility, metoclopramide can be helpful.

 

Content 3

 

 

 

 

 

Care pays attention to the physical, psychological, social, and spiritual needs of a patient.

Communication and continuous assessment of management goals are key components to addressing end-of-life care. Physicians must be clear about the likely outcome of the illness(es) and provide an anticipated schedule with goals and landmarks in the care process. When the goals of care have changed from cure to palliation, that transition must be clearly explained and defended.

Seven steps are involved in establishing goals:

  1. Ensure that the medical information is as complete as possible and understood by all relevant parties.

  2. Explore the pt’s goals while making sure the goals are achievable.

  3. Explain the options.

  4. Show empathy as the pt and the family adjust to changing expectations.

  5. Make a plan with realistic goals.

  6. Follow-through with the plan.

  7. Review and revise the plan periodically as the pt’s situation changes.

ADVANCE DIRECTIVES

About 70% of pts lack decision-making capacity in their final days. Advance directives define ahead of time the level of intervention the pt is willing to accept. Two types of legal documents can be used: the advance directive, in which specific instructions from the pt may be made known; and the durable attorney for health care, in which a person is designated as having the pt’s authority to make health decisions on pt’s behalf. Forms are available free of charge from the National Hospice and Palliative Care Organization (www.nhpco.org). Physicians also should complete these forms for themselves.

PHYSICAL SYMPTOMS AND THEIR MANAGEMENT

The most common physical and psychological symptoms among terminally ill pts are shown in Table 9-1. Studies of pts with advanced cancer have shown that pts experience an average of 11.5 symptoms.

When taking care of patients with low functional reserve the physician should transition from cure to palliative care. At the terminal phase of life care shifts from intervention to comfort.

 

Optimal care depends on a comprehensive assessment of pt needs in all four domains affected by illness: physical, psychological, social, and spiritual. A variety of assessment tools are available to assist in the process.

Communication and continuous assessment of management goals are key components to addressing end-of-life care. Physicians must be clear about the likely outcome of the illness(es) and provide an anticipated schedule with goals and landmarks in the care process.

When the goals of care have changed from cure to palliation, that transition must be clearly explained and defended. Seven steps are involved in establishing goals:

  1. Ensure that the medical information is as complete as possible and understood by all relevant parties.

  2. Explore the pt’s goals while making sure the goals are achievable.

  3. Explain the options.

  4. Show empathy as the pt and the family adjust to changing expectations.

  5. Make a plan with realistic goals.

  6. Follow-through with the plan.

  7. Review and revise the plan periodically as the pt’s situation changes.

 

Communications with the family, friends, and all caregivers must be timely, consistent (having only one physician serve as the spokesman has great advantages), accurate, clear to laypersons, advisory without being dictatorial, focused on what is best for the patient, and aligned with the patient’s wishes. A gradual stepwise approach over time allows family members and friends time to digest the information; get beyond their normal, initial reactions to the bad news; and make the difficult decision to withdraw intensive support.

It is important to recognize two ethical principles. The first is the principle of double effect. All medical interventions have potential benefits as well as burdens and risks. If the doses of morphine or sedative drug required to relieve pain and agitation result in unintended side effects, we accept them, even if the result is death.This is not euthanasia. The second principle is that withdrawal of medical therapies and interventions is no different from withholding them: both may be done to respect the patient’s autonomy. 1

Eliciting patient’s goals as to what they want and what they want to avoid is fundamental to crafting an end-of-life framework that is consistent with their values and preferences. Home visits enhance this relationship and often reveal opportunity for interventions and support.1

The patient should decide where he/she will spend his/her final days.

Identify what type of palliative care and hospice care patient wishes to receive. Help patient find hospice care, what happens at the time of death, managing grief, and preparing advance directives. Advance directives can help make patient wishes clear to your family and health care providers. Terminal illness may close the door to the possibility of a cure, but it does not end the need for comfort support. Nor does it end the involvement of family and friends.

Essay: Dying with Dignity in the Intensive Care Unit1

Despite technological advances, death in the intensive care unit (ICU) remains commonplace.

When the organ dysfunction of critical illness defies treatment, when the goals of care can no longer be met, or when life support is likely to result in outcomes that are incongruent with patients' values, ICU clinicians must ensure that patients die with dignity. The definition of “dying with dignity” recognizes the intrinsic, unconditional quality of human worth but also external qualities of physical comfort, autonomy, meaningfulness, preparedness, and interpersonal connection.3 Respect should be fostered by being mindful of the “ABCDs” of dignity-conserving care (attitudes, behaviors, compassion, and dialogue)4 (Table 1TABLE 1Examples of the ABCDs of Dignity-Conserving Care.). Preserving the dignity of patients, avoiding harm, and preventing or resolving conflict are conditions of the privilege and responsibility of caring for patients at the end of life. In our discussion of principles, evidence, and practices, we assume that there are no extant conflicts between the ICU team and the patient's family. Given the scope of this review, readers are referred elsewhere for guidance on conflict prevention and resolution in the ICU.5,6

The concept of dying with dignity in the ICU implies that although clinicians may forgo some treatments, care can be enhanced as death approaches. Fundamental to maintaining dignity is the need to understand a patient's unique perspectives on what gives life meaning in a setting replete with depersonalizing devices. The goal is caring for patients in a manner that is consistent with their values at a time of incomparable vulnerability, when they rarely can speak for themselves.7 For example, patients who value meaningful relationships may decline life-prolonging measures when such relationships are no longer possible. Conversely, patients for whom physical autonomy is not crucial may accept technological dependence if it confers a reasonable chance of an acceptable, albeit impaired, outcome.8 At issue is what each patient would be willing to undergo for a given probability of survival and anticipated quality of life.

ON THE NEED FOR PALLIATIVE CARE

The coexistence of palliative care and critical care may seem paradoxical in the technological ICU. However, contemporary critical care should be as concerned with palliation as with the prevention, diagnosis, monitoring, and treatment of life-threatening conditions.

The World Health Organization defines palliative care as “an approach that improves the quality of life of patients and their families facing the problems associated with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial and spiritual.”9 Palliative care, which is essential regardless of whether a medical condition is acute or chronic and whether it is in an early or a late stage, can also extend beyond the patient's death to bereaved family members10(Figure 1FIGURE 1Curative and Palliative Approaches to Care throughout a Critical Illness.).

ELICITING THE VALUES OF PATIENTS

Sometimes it is too late. A precipitating event prompting an ICU admission that occurs within a protracted downward trajectory of an illness may be irreversible. When clinicians who are caring for a patient in such a scenario have not previously explored whether the patient would want to receive basic or advanced life support, the wishes of the patient are unknown, and invalid assumptions can be anticipated. Effective advance care planning, which is often lacking in such circumstances, elicits values directly from the patient, possibly preventing unnecessary suffering associated with the use of unwelcome interventions and thereby preserving the patient's dignity at the end of life.

Regardless of the rate and pattern of decline in health, by the time that patients are in the ICU, most cannot hold a meaningful conversation as a result of their critical condition or sedating medications. In such cases, family members or other surrogates typically speak for them. In decisions regarding the withdrawal of life support, the predominant determinants are a very low probability of survival, a very high probability of severely impaired cognitive function, and recognition that patients would not want to continue life support in such circumstances if they could speak for themselves.11 Probabilistic information is thus often more important than the patient's age, coexisting medical conditions, or illness severity in influencing decisions about life-support withdrawal.

Discussions can be initiated by eliciting a narrative from patients (or more commonly, from family members) about relationships, activities, and experiences treasured by the patient. The use of engaging, deferential questions, such as “Tell me about your . . .” or “Tell us what is important to . . . ,” is essential. Clinician guidance for constructing an authentic picture of the incapacitated patient's values is offered in the Facilitated Values History,8 a framework that provides clinicians with strategies for expressing empathy, sensitively depicting common scenarios of death, clarifying the decision-making role of surrogates, eliciting and summarizing values most relevant to medical decision making, and linking these values explicitly to care plans.

COMMUNICATION

Before a critical illness develops, patients' perceptions about what matters most for high-quality end-of-life care vary, but human connections are key. Many seriously ill elderly patients cite effective communication, continuity of care, trust in the treating physician, life completion, and avoidance of unwanted life support.12 After critical illness develops, most patients or their surrogates find themselves communicating with unfamiliar clinicians in a sterile environment at a time of unparalleled distress. Challenges in communication are magnified when patients die at an early stage of critical illness, before rapport has been well established.

Clear, candid communication is a determinant of family satisfaction with end-of-life care.13 Notably, measures of family satisfaction with respect to communication are higher among family members of patients who die in the ICU than among those of ICU patients who survive, perhaps reflecting the intensity of communication and the accompanying respect and compassion shown by clinicians for the families of dying patients.14 The power of effective communication also includes the power of silence.15 Family satisfaction with meetings about end-of-life care in the ICU may be greater when physicians talk less and listen more. 16

DECISION MAKING

Decision-making models for the ICU vary internationally but should be individualized. At one end of the continuum is a traditional parental approach, in which the physician shares information but assumes the primary responsibility for decision making. At the other end of the continuum, the patient makes the decisions, and the physician has an advisory role. In North America and in some parts of Europe,17 the archetype is the shared decision-making model, in which physicians and patients or their surrogates share information with one another and participate jointly in decision making.18

Although preferences for decision-making roles vary among family members,19 physicians do not always clarify family preferences.20 Family members may lack confidence about their surrogate decision-maker role, regardless of the decision-making model, if they have had no experience as a surrogate or no prior dialogue with the patient about treatment preferences.21 Decision-making burden is postulated as a salient source of strain among family members of patients who are dying in the ICU; anxiety and depression are also prevalent.22,23

PROVIDING PROGNOSTIC INFORMATION

Valid prognostic information is a fundamental component of end-of-life discussions. Understanding the predicted outcome of the critical illness and recognizing the uncertainty of that prediction are helpful in making decisions that reflect the patient's values. However, when it comes to prognosticating for seriously ill patients, families and physicians sometimes disagree.24 In one study, surrogate decision makers for 169 patients in the ICU were randomly assigned to view one of two videos of a simulated family conference about a hypothetical patient.25 The videos varied only according to whether the prognosis was conveyed in numerical terms (“10% chance of survival”) or qualitative terms (“very unlikely to survive”). Numerical prognostic statements were no better than qualitative statements in conveying the prognosis. However, on average, surrogates estimated twice as often as physicians that the patient would survive.

In another study, when 80 surrogates of patients in the ICU interpreted 16 prognostic statements, interviews suggested an “optimism bias,” in which the surrogates were likely to interpret the physicians' grim prognostication as positive with respect to the patient's condition.26 Clinicians should recognize that family members who are acting as spokespersons for patients in the ICU are often “living with dying” as they face uncertainty while maintaining hope.27 Hope should be respected during prognostic disclosure28 while a realistic view is maintained, an attitude that is aptly expressed by the simple but profound notion of “hoping for the best but preparing for the worst.”29

MAKING RECOMMENDATIONS

Physicians in the ICU sometimes make recommendations to forgo the use of life-support technology. In one study involving surrogates of 169 critically ill patients, 56% preferred to receive a physician's recommendation on the use of life support, 42% preferred not to receive such a recommendation, and 2% stated that either approach was acceptable.30 A recent survey of ICU physicians showed that although more than 90% were comfortable making such recommendations and viewed them as appropriate, only 20% reported always providing recommendations to surrogates, and 10% reported rarely or never doing so. 31 In this study, delivering such recommendations was associated with perceptions about the surrogate's desire for, and agreement with, the physician's recommendations. Other potential influences are uncertainty, personal values, and litigation concerns.

Asking families about their desire for recommendations from physicians can be a starting point for shared deliberations about care plans.32 Eliciting preferences for how patients or their families wish to receive information, particularly recommendations concerning life support, is not an abnegation of responsibility but rather an approach that is likely to engender trust. Physicians should judiciously analyze each situation and align their language and approach with the preferred decision-making model, understand interpersonal relationships, and avoid overemphasizing a particular point of view. For example, in the shared decision-making model of care for dying patients, family discussions typically include a review of the patient's previous and present status and prognosis, elicitation of the patient's values, presentation of the physician's recommendations, deliberations, and joint decision making about ongoing levels of care.

PROVIDING HOLISTIC CARE

Cultivating culturally and spiritually sensitive care is central to the palliative approach. The pillars of both verbal and nonverbal communication are crucial. Conscious nonverbal communication is rarely practiced yet can be as powerful as verbal communication during end-of-life decision making. Physicians should be aware of the cultural landscape reflecting an institution's catchment area, how cultural norms can influence admissible dialogue, and what is desirable versus dishonoring in the dying process.33

The meaning assigned to critical illness, particularly when death looms, is frequently interpreted through a spiritual lens. For many people, critical illness triggers existential questions about purpose (of life, death, and suffering), relationships (past, present, and future), and destiny. Clinicians should be able to pose questions about spiritual beliefs that may bear on experiences with respect to illness. Introductory queries can open doors, such as “Many people have beliefs that shape their lives and are important at times like this. Is there anything that you would like me to know?”34 A useful mnemonic for obtaining ancillary details is SPIRIT, which encompasses acknowledgment of a spiritual belief system, the patient's personal involvement with this system, integration with a spiritual community, ritualized practices and restrictions, implications for medical care, and terminal-events planning34 (Table 2TABLE 2Taking a Spiritual History.).

Although it is unrealistic to expect that clinicians will be familiar with the views of all the world religions regarding death, they should be cognizant of how belief systems influence end-of-life care.35 Physicians may recommend different approaches to similar situations, depending on their religious and cultural backgrounds, as has been self-reported36 and documented in observational studies.37 Insensitivity to faith-based preferences for discussion and decision making may amplify the pain and suffering of both patients and their families. Clinicians should understand how spirituality can influence coping, either positively or negatively.38 Chaplains are indispensable for addressing and processing existential distress, conducting life review, and facilitating comforting prayers, rituals, or other observances.

THE FINAL STEPS

If a shift is made in the goals of care from cure to comfort, it should be orchestrated with grace and should be individualized to the needs of the patient.39 Before proceeding with end-of-life measures, it is necessary to prepare staff members and the patient's room, as well as the patient (Table 3TABLE 3Practical Preparatory Procedures to Ensure Patient Dignity before Withdrawal of Life Support.). The panoply of basic and advanced life-support equipment and the mechanics of their deployment or discontinuation are chronicled in multiple studies, as well as in discussion documents, consensus statements from professional organizations, and task-force reports.10,17,32,40 Strategies should be openly discussed and informed by the same balance of benefits, burdens, and respect for the preferences of patients and their surrogates that apply to other aspects of end-of-life care.10

There is no single, universally accepted technical approach. Admissible strategies in most settings include variations and combinations of non-escalation of current interventions, withholding of future interventions, and withdrawal of some or all interventions, except those needed for comfort. When life-support measures are withdrawn, the process of withdrawal — immediate or gradual discontinuation — must be considered carefully. Mechanical ventilation is the most common life-support measure that is withdrawn. 11 However, even in the case of mechanical ventilation, legal or faith-based requirements, societal norms, and physician preferences influence decisions about withdrawal.32 The initiation of noninvasive ventilation with clear objectives for patients who are not already undergoing mechanical ventilation can sometimes reduce dyspnea and delay death so that the patient can accomplish short-term life goals.41 Whatever approach is used, individualized pharmacologic therapy, which depends on prevailing levels of analgesia and sedation at the time of decisions to forgo life support, should ensure preemptive, timely alleviation of dyspnea, anxiety, pain, and other distressing symptoms.42 Clinicians can mitigate the stress of family members by discussing what is likely to happen during the dying process (e.g., unusual sounds, changes in skin color, and agonal breathing). Physician attendance is paramount to reevaluate the patient's comfort and talk with the family as needed (Table 4TABLE 4Considerations and Cautions in the Withdrawal of Life Support.).

CONSEQUENCES FOR CLINICIANS

Dying patients and their families in the ICU are not alone in their suffering. For some clinicians, views about the suitability of advanced life support that diverge from those of the patient or family can be a source of moral distress. Clinicians who detect physical or psychic pain and other negative symptoms may suffer indirectly, yet deeply. Vicarious traumatization results from repeated empathic engagement with sadness and loss,43 particularly when predisposing characteristics amplify clinicians' response to this workplace stress. Clinicians should be aware of how their emotional withdrawal or lability and “compassion fatigue” can jeopardize the care of dying patients and their families.

Informal debriefing or case-based rounds,44 local meetings with other professionals, modified work assignments, and other strategies may help clinicians to cope with the distress.45 Formal bereavement counseling that is designed especially for involved clinicians can enhance awareness about vicarious traumatization and encourage adaptive personal and professional coping strategies.

END-OF-LIFE CARE AS A QUALITY-IMPROVEMENT TARGET

Palliative care is now a mainstream matter for quality-improvement agendas in many ICUs. A decade ago, the Robert Wood Johnson Foundation Critical Care End-of-Life Peer Workgroup and 15 associated nurse–physician teams in North America conducted a review of reported practices for end-of-life care and named seven key domains for quality improvement: patient- and family-centered decision making, communication, continuity of care, emotional and practical support, symptom management, spiritual support, and emotional and organizational support for ICU clinicians.46 More than 100 potential interventions were identified as part of this project, directed at patients and their families, clinicians, ICUs, and health care systems. Candidate quality indicators and “bundled indicators” can facilitate measurement and performance feedback in evaluating the quality of palliative care in ICU settings.47

In a multicenter, randomized trial involving critically ill patients who were facing value-related conflicts, ethics consultations helped with conflict resolution and reduced the duration of nonbeneficial treatments that the patients received. 48 In a subsequent cluster-randomized trial involving 2318 patients in which investigators evaluated a five-component, clinician-focused end-of-life strategy,49 there were no significant differences between groups with respect to family satisfaction with care, family or nurse ratings of the quality of dying, time to withdrawal of mechanical ventilation, length of stay in the ICU, or other palliative care indicators.

Favorable assessments of palliative care interventions in the ICU are beginning to emerge. In one study, family members of 126 dying patients in 22 ICUs were randomly assigned to participate in a standard end-of-life family conference or to participate in a proactive family conference and receive a brochure on bereavement.50 The mnemonic “VALUE” framed the five objectives of the proactive family conference: value and appreciate what family members say, acknowledge the family members' emotions, listen to their concerns, understand who the patient was in active life by asking questions, and elicit questions from the family members. Patients whose family members were assigned to the proactive-conference group were treated with significantly fewer nonbeneficial interventions after the family conference than were those whose family members were assigned to the standard-conference group, with no significant between-group difference in the length of stay in the ICU or the hospital. Caregivers in the proactive-conference group, as compared with the standard-conference group, were less negatively affected by the experience and were less likely to have anxiety, depression, and symptoms of post-traumatic stress 90 days after the patients' deaths.

CONCLUSIONS

Palliative care in the ICU has come of age. Its guiding principles are more important than ever in increasingly pluralistic societies. Ensuring that patients are helped to die with dignity begs for reflection, time, and space to create connections that are remembered by survivors long after a patient's death. It calls for humanism from all clinicians in the ICU to promote peace during the final hours or days of a patient's life and to support the bereaved family members. Ensuring death with dignity in the ICU epitomizes the art of medicine and reflects the heart of medicine. It demands the best of us.



 

 



 Care of the Imminently Dying

But defining when this phase actually begins is not straightforward. Is it when the patient is in the last hours of life, or does it begin earlier, when a potentially incurable illness is diagnosed? What about patients who die suddenly? About 1 in 10 people die without any warning, with no preceding illness, and with no time for care.[2] Medical advances such as device therapy for heart failure and noninvasive ventilation for chronic obstructive pulmonary disease have revolutionized end-stage disease and made it more difficult to clearly recognize a dying phase.

Making the diagnosis of dying is essential for good end-of-life care. Barriers to the diagnosis need to be overcome (Box 177-1).[3] Failure to make the diagnosis has negative consequences, not only for the patient but also for the family and health care professionals. The patient may experience uncontrolled symptoms. Inappropriate treatment plans may be instituted, including cardiopulmonary resuscitation. Patients and relatives may get conflicting messages, potentially resulting in loss of trust, dissatisfaction, and formal complaints. Health care professionals may become disillusioned with inappropriate management of patients, causing disharmony within the team. If team members disagree, then mixed messages and opposed goals can cause poor patient management and confused communication.

In the past, health care professionals have been reluctant to make the diagnosis of dying, because it seemed akin to giving up–an admission that nothing more could be done. Such reluctance is no longer acceptable. In fact, this is the very moment when the hospice model of intensive palliative care should come into action, providing physical, psychological, social, and spiritual care for patients and their relatives (Box 177-2).

The physical moment of death can usually be recognized as the cessation of breathing and the absence of a pulse. However, the medicalization of dying has made recognition of the moment of death challenging.

Barriers to the Acceptance of Dying

       Unrealistic expectation that the patient may get better
       Disagreement within the team or with the family that the patient is dying
       No definitive diagnosis
       Lack of knowledge of the management of pain and other symptoms at the end of life
       Poor communication skills
       Concerns about withdrawing or withholding treatment
       Fear of foreshortening life
       Misinterpretation of the principle of double effect
       Concerns about resuscitation
       Cultural and spiritual barriers
       Legal complexities

Box 177-2 
Goals of Care for Patients in the Dying Phase

       Use a problem-solving approach to symptom control
       Avoid unnecessary interventions
       Perform regular review of drugs and symptoms
       Address psychological and insight issues
       Provide religious and spiritual support for the patient
       Communicate with family and carers
       Update the primary health care team

CLINICAL EVALUATION Dying

Dying is a dynamic process. The concept of a dying trajectory, first suggested in 1965, refers to the change in health status over time as death approaches.[4] The process is influenced by many factors, the most important of which is the underlying disease.[5] It is remarkable how similar dying trajectories can be for comparable diseases.

There are four prototypal death trajectories. Some people die suddenly without warning. Figure 177-1 shows the three other trajectories: steady progression and a predictable terminal phase, gradual decline punctuated by episodes of acute deterioration, and prolonged gradual decline.[6,7]

Click to view full size figure

FIGURE 177-1  Death trajectories. Rights were not granted to include this figure in electronic media. Please refer to the printed book.
(Adapted from Lunney JR, Lynn J, Hogan C. Profiles of older Medicare decedents. J Am Geriatr Soc 2002;50:1108-1112.


When patients are within days or weeks of death, certain signs are present. Alone, these signs could be related to potentially reversible causes. When present together, they are more likely to represent an irreversible process. The following are signs of approaching death:

       Bedridden or able to get out of bed only with great difficulty
       Profound weakness
       Little interest in food and drink
       Difficulty swallowing
       Increasingly somnolent

In the final days and hours of life, the following signs will probably be present:

       Skin gets cold, from the periphery inward
       Skin feels clammy
       Color of the skin of the extremities and around the mouth may become cyanotic
       Urine output may decrease
       Level of consciousness will diminish
       Patient may “rattle” when breathing
       Respiration is irregular and shallow–a Cheyne-Stokes pattern
       The face may look waxen
       The muscles of the face may relax, and the nose may become more prominent

Nursing staff in direct contact with the patient may be the first to recognize that the patient is dying. Patients should be assessed regularly, because the goals of care should be revised to meet the rapidly changing clinical situation.

Altered States of Consciousness That May Precede Death

Consciousness was first defined in 1890 as awareness of the self and the environment.[8] Consciousness has two dimensions: wakefulness and awareness. Altered states of consciousness, from mild delirium to coma, often precede death.

Delirium

Delirium is defined as a transient organic brain syndrome that is characterized by the onset of disordered attention and cognition and is accompanied by disturbances of psychomotor behavior and perception.[9] It is observed in up to 88% of patients before death (see  Chapter 156).[10]

Coma

Coma is a state in which a person is totally unaware of both self and external surroundings and is unable to respond meaningfully to external stimuli.[8] Coma results from gross impairment of both cerebral hemispheres and/or the ascending reticular activating system. Causes can be classified as either focal or diffuse brain dysfunction. The truly comatose patient is deeply unconscious, with no response to pain. If coma cannot be reversed, it will progress to irreversible brain damage and death.

Vegetative State

A vegetative state is a clinical condition of complete unawareness of the self and the environment in which the patient breathes spontaneously, has a stable circulation, and shows cycles of eye closure and opening that may simulate sleep and waking.[11] Persistent vegetative state is a vegetative state that is present 1 month after acute traumatic or nontraumatic brain injury. A permanent vegetative state is a vegetative state that is present for 12 months or longer.

The diagnosis of a vegetative state can be made if (1) there is no behavioral evidence of awareness of self or environment; (2) there is brain damage, usually of known cause, consistent with the diagnosis; and (3) there are no reversible causes. All available sources of information should be used when making the diagnosis; all written records, including nursing notes, should be reviewed, and staff who have cared for the patient over time should be interviewed. It is particularly important to interview family members. They may observe behavior that indicates awareness, and their opinion on the patient's level of awareness must be sought.

A patient in a vegetative state is unable to give or imply consent. The probability of recovery from a vegetative state is very low, and decisions about continuation of medical care are usually referred to the courts.[11] Any decision to withdraw feeding should be consistent with the principles of autonomy, nonmaleficence, beneficence, and justice. After artificial nutrition and hydration are withdrawn, a patient in a persistent vegetative state usually dies within 10 to 14 days.[12] The immediate cause of death is dehydration and electrolyte imbalance. Some die from intercurrent acute illnesses, such as pneumonia. Others may die from underlying cardiac or renal disease if medications are also discontinued.

The question arises whether patients in a permanent vegetative state can experience pain and suffering. The perceptions of pain and suffering are conscious experiences: unconsciousness, by definition, precludes them. It is unlikely that people in true vegetative states experience pain, but grimace-like or crying-like behaviors are common. These patterned behaviors are mediated at the subcortical level and are not manifestations of perceived pain.[13]

In rare cases, there may be uncertainty as to the diagnosis. For example, it may be difficult to distinguish a persistent vegetative state from a severe locked-in state. A locked-in syndrome is a state in which consciousness and cognition are retained but movement and communication are impossible because of severe involuntary motor paralysis.[14] The syndrome can occur with diseases of the peripheral motor nervous system such as motor neuron disease. Under such circumstances, a patient may be unable to express behavioral responses to painful stimuli, or the responses may be extremely difficult to detect; the absence of a response cannot be taken as proof of the absence of consciousness. If there is any doubt about the diagnosis and the ability of the patient to perceive pain, it is best to err on the side of caution and administer analgesia.

Diagnosis of Death and Dying
The diagnosis of dying is central to optimal management at the end of life.
Altered states of consciousness may precede death, including delirium, coma, and persistent vegetative state.
Natural death is defined by the absence of cardiorespiratory function.
Brain death is defined as the irreversible cessation of all functions of the entire brain, including the brainstem.
Unnatural death requires legal investigation.

 

Reference

 

Norma O'Leary CHAPTER 177 – Diagnosis of Death and Dying in

Walsh: Palliative Medicine , 1st ed.

Euthanaisa: http://euthanasia.procon.org/

 


 

Ethical Considerations and Controversy

To many patients facing a fatal illness, the goals of

  • Testing until diagnoses are well-established
  • Correcting all physiologic abnormalities, even asymptomatic ones
  • Pursuing a cure, even when cure is unlikely and therapy is toxic, invasive, or uncomfortable
may be less important than

Avoiding suffering

With their family and friends) finding comfort

and meaningfulness during the experience of dying.

Thecare of the dying patient should be guided by a realistic assessment of the situation and the merits of various interventions in light of the patient's values and wishes.

 

 

 

People's priorities differ, especially when facing death. Some prefer life to be prolonged, even at the cost of pain, marked confusion, or severe respiratory distress. They may cherish every moment of life, regardless of its quality. For others, quality of life is the overarching concern. They may fear pain or confusion more than death and prefer comfort measures and shorter survival to prolonged disability and struggle. However, to say that a patient's care has changed from curative to supportive or from treatment to palliation is an oversimplification of a complex decision process. Most patients need a customized mix of treatment to correct, prevent, and mitigate the effects of various illnesses and disabilities.



Some people search for closure: They reach out to friends and family to share time and to express love; they complete projects important to their lives and tie up loose ends. Often, with appropriate support, people die at a time and in a way that allows them to experience a satisfying close. Other people cannot accept their imminent mortality and avoid such closure.

Effective care for dying patients usually involves a clinical team because no one caregiver is available 24 h/day and because comprehensive, reliable care requires the skills and perspectives of several disciplines. Palliative care or hospice teams anticipate potential problems and make appropriate arrangements, such as obtaining supplies or opioids in anticipation of a potential emergency. Certain team members can help dying patients who have spiritual needs; such needs should be recognized, acknowledged, and addressed. When death is imminent, an experienced team member can comfort family members and may prevent an inappropriate call to the emergency medical system.

When Death Is Near

The physician and the clinical team should prepare patients and family members for death whenever patients have a condition likely to worsen and cause death, even if death may be a few years in the future. Preparation includes discussion of the likely course and possible complications. Patients should also be advised when death becomes imminent. A health care practitioner must not assume that patients or family members understand the fatal nature of certain disorders (even metastatic cancer) or that they can recognize from a patient's appearance that death is near. Initial discussions should be honest and sensitive to the language and culture of patients and family members. The physician should not delay full disclosure too long because doing so can provide false hope and distort decision making¾for example, by reducing the opportunity to attend to spiritual and family concerns. Many patients and family members benefit from making plans based on their priorities and preferences for end-of-life treatments (see p. 3471).

Many patients ask whether the clinician can predict the time until death. Such estimates are ordinarily incorrect, both for slowly progressive disorders and for disorders in which death tends to come suddenly, without reliable warning signs (eg, heart failure, emphysema). For some cancers, recognizable warning signs may presage death by several weeks or months. In contrast, many people live for months or years in an unchanging but very fragile state of health. Clinicians tend to give inaccurately optimistic estimates and often are reluctant to predict life expectancy. Some models, such as the Acute Physiologic Assessment and Chronic Health Evaluation II (APACHE II) used to predict in-hospital mortality for ICU patients, are accurate for groups but not for individuals. If a clinician notes that a patient is sick enough that it would be "no surprise" for the patient to die in the coming year, the patient could die with the next complication, which could develop at any time. In such cases, clinicians, patients, and family members should consider prioritizing comfort and life closure over at least the burdensome elements in conventional medical treatment, as well as many preventive services. Family support, advance care planning, focus on relieving symptoms and maximizing function, and attention to spiritual issues are appropriate for patients who are in such fragile health. Clinicians lose many opportunities to help patients and their families live well and meaningfully by postponing the recognition of fragile health until death is clearly imminent.

At some point, virtually every dying patient should have a do-not-resuscitate (DNR) order or a do-not-attempt-resuscitation (DNAR) order written in the medical record. All clinicians in every setting should abide by that decision. Patients, family members, and the clinical team should also make and record other important decisions about medical care (eg, whether patients are to be hospitalized or use a ventilator). Often, implementing these decisions requires specific actions (eg, to have the needed drugs at home).

Family members should know about the changes that may occur in the patient's body shortly before and after death. They should not be surprised by irregular breathing, cool extremities, confusion, a purplish skin color, or somnolence in the last hours.

Some patients close to death develop noisy bronchial congestion or palatal relaxation, commonly known as the death rattle. If this symptom distresses family members, scopolamine or diphenhydramine (see p. 3485) can dry the patient's secretions and reduce the noise. Also, CNS irritability, with agitation and restlessness, may develop. If these symptoms, after review, are judged not to be caused by a drug or untreated disorder, they can be relieved by a sedative.

If a patient is expected to die at home, family members should rehearse whom to call (eg, physician, hospice nurse, clergy) and know whom not to call (eg, ambulance service, 911). They should also have help in obtaining legal advice and arranging burial or cremation services. Religious practices that may affect after-death care of the body should be discussed before death with the patient, family members, or both.

The last moments of a patient's life can have a lasting effect on family members, friends, and caregivers. The patient should be in an area that is peaceful, quiet, and physically comfortable. Any stains or tubes on the bed should be covered, and odors should be masked. Family members should be encouraged to maintain physical contact, such as holding hands, with the patient. If desired by the patient and family members, the presence of friends and clergy should be encouraged. Accommodation should be made for spiritual, cultural, ethnic, or personal rites of passage desired by the patient and family members.

When resuscitation is attempted, family members often appreciate being present during the resuscitation.

After Death Occurs

A physician, nurse, or other authorized person should pronounce the patient dead in a timely way to reduce the family's anxiety and uncertainty. The physician should complete the death certificate as soon as possible because funeral directors need a completed death certificate to make final arrangements. Even when death is expected, physicians may need to report the death to the coroner or police; knowledge of local law is important.

Telling family members about death, particularly unexpected death, requires effort. The physician should use clear language when informing the family that death has occurred (eg, using the word "died"). Euphemisms (eg, "passed on") should not be used because they are easily misinterpreted. If the family was not present during resuscitation, any events near death, including resuscitative efforts, should be described and the patient's absence of pain and distress mentioned (if true). It is usually wise to be sure that the closest kin is not alone. When told about death, particularly unexpected death, family members may be overwhelmed and unable to process information given to them or to formulate questions. Physicians, nurses, and other health care practitioners should respond to the psychologic needs of family members and provide appropriate counseling, a comfortable environment where family members can grieve together, and adequate time for them to be with the body. When feasible, it may help for a clinician to be with the family members as they enter the room with a newly dead body because that situation is so unfamiliar to most people. Sometimes it is best then to leave family members alone for a while, then return and offer explanations of treatments provided and give the family a chance to ask questions. Friends, neighbors, and clergy may be able to help provide support. Health care practitioners should be sensitive to cultural differences in behavior at the time of death.

The patient or family members and the clinical care team should discuss organ and tissue donation, if appropriate, before death or immediately after death; such discussions are ordinarily mandated by law. The attending physician should know how to arrange for organ donation and autopsy, even for patients who die at home or in a nursing home. Autopsy should be readily available regardless of where the death occurred, and decisions about autopsies can be made before death or just after death. A substantial minority of families welcome an autopsy to clear up uncertainties, and clinicians should appreciate the role of autopsy in quality assessment and improvement.


Hospice Care

· Emphasis on symptom relief and comfort care

· Decreased emphasis on prolonging life

· Little diagnostic testing

Hospice is a concept and program of care that is specifically designed to minimize suffering for dying patients and their family members. In the US, hospice is the only widely available comprehensive program to support very sick people at home. Philosophically, hospice programs forgo most diagnostic testing and life-prolonging treatments in favor of symptom relief, education of patients and family members about appropriate care, and comfort care.

Hospice is always interdisciplinary, relying on a core team of physicians, nurses, social workers, and attendants (eg, home health aides). Pharmacists, nutritionists, and therapists may also be involved. Hospice program personnel care for patients at home, in nursing homes, or in other care facilities. Although hospice program personnel do not usually care for patients in hospitals and rehabilitation centers, many hospitals are establishing palliative care programs to address the same care issues.

Hospice programs differ substantially in the services they provide and in treatments and devices they use. Whether a particular patient and family should participate in a given program depends on their needs and wishes, on their financial considerations, and on the skills and capacity of the local programs.

Hospice care can provide most necessary medical treatments. Nurses ordinarily oversee and implement the general plan of care, including drug use, O2 therapy, and IV lines or other special equipment. Nurses are usually the first ones to assess and address patient needs. They can usually adjust drug doses and help obtain any new drugs or treatments. Hospice physicians see patients when needed and share in shaping the plan of care. Social workers, chaplains, and volunteers help with interpersonal, spiritual, and financial issues. Bereavement counselors support survivors through the grieving process. Hospice plans of care help family members prepare for the challenges of facing the death of a loved one and dealing with the situation at the time of death, including their role and how to obtain needed help.

Most patients ill enough to require hospice also require some assistance with daily activities (eg, dressing, bathing, preparing food), and some may be completely dependent. Family members and friends often provide this care, but additional help from home health aides and volunteers may be necessary.

Medicare or insurance mostly pays a per diem rate that is intended to cover all hospice services, including a negotiated amount of help from home health aides, but only after a physician certifies that the patient has a fatal disorder with life expectancy < 6 mo.

Physicians may be reluctant to use hospice because a treatable condition could develop. However, this reluctance is not justified because many treatable conditions are within the scope of hospice care, and patients can leave hospice at any time and re-enroll later.

Other Concerns

Patient, family members, and clinicians should consider the following:

· They should plan for increasing disability.

· Obtaining payment for end-of-life care may be difficult.

· Emphasis should be on improving quality of end-of-life, not on hastening death.

Managing disability: Progressive disability often accompanies fatal illnesses. Patients may gradually become unable to tend to a house or an apartment, prepare food, handle financial matters, walk, or care for themselves. Most dying patients need help during their last weeks. Disability should be anticipated and appropriate preparations made (eg, choosing housing that is wheelchair-accessible and close to family caregivers). Services such as occupational or physical therapy and hospice care may help a patient remain at home, even when the disability progresses.

Financial concerns: Financial coverage for care of dying patients is problematic. Medicare regulations restrict payment for many aspects of supportive care. Not all patients qualify for hospice care, and physicians are often reluctant to certify the 6-mo prognosis required for hospice coverage. Sometimes the need for skilled nursing care can justify Medicare payment to a nursing home for short-term, complex medical and nursing needs for dying patients. One study has shown that one third of families deplete most of their savings when caring for a dying relative. The clinical care team should know the financial effects of choices and discuss these issues with patients or family members. Some attorneys specialize in elder care and can help patients and their family members deal with these issues.

Legal and ethical concerns: Health care practitioners should know local laws and institutional policy governing living wills, durable powers of attorney, and procedures for forgoing resuscitation and hospitalization. This knowledge helps them ensure that the patient's wishes guide care, even when the patient can no longer make decisions (see p. 3468).

Many health care practitioners worry that medical treatments intended to relieve pain or other suffering can hasten death, but this effect is actually quite uncommon. With thoughtful and skillful medical care, accusations of assisted suicide or other wrongdoing are almost nonexistent. Even if dyspnea requires doses of opioids that may also hasten death, the resulting death is not considered wrongful.

However, actually assisting with suicide (eg, by directly providing a dying patient with lethal drugs and instructions for using them) could be grounds for prosecution in most states but is authorized under specific conditions in Oregon. Charges of homicide are plausible if the patient's interests are not carefully advocated, if the patient lacks capacity or is severely functionally impaired when decisions are made, if decisions and their rationales are not documented, or if the prosecutor's electoral base is expected to approve of such charges. Physicians who manage symptoms vigorously and forgo life-sustaining treatment need to document decision making carefully, provide care in a reputable setting, and discuss these issues willingly, honestly, and sensitively with patients, other practitioners, and the public. A physician should not provide an intervention that is conventionally considered a means of homicide (eg, lethal injection) even if the intention is to relieve suffering.

Symptom Control in the Dying

Patients need reassurance that symptoms will not be overwhelming.

Physical and mental distress is common while living with fatal illness, but much distress can be prevented or relieved. Patients commonly fear protracted and unrelieved suffering. Knowing they can count on living reasonably comfortably enables patients to focus on living as fully as possible and on confronting the issues presented by fragile health and the approach of death.

Symptom control should be based on etiology when possible. For example, vomiting due to hypercalcemia requires different treatment from that due to elevated intracranial pressure. However, diagnosing the cause of a symptom may be inappropriate if testing is burdensome or risky or if specific treatment (eg, major surgery) has already been ruled out. For dying patients, comfort measures, including nonspecific treatment or a short sequential trial of empiric treatments, are often better than an exhaustive diagnostic evaluation.

Because one symptom can have many causes and may respond differently to treatment as the patient's condition deteriorates, the clinical team must monitor and reevaluate the situation frequently. Drug overdosage or under-dosage is harmful, and both become more likely as worsening physiology causes changes in drug disposition.

When survival is likely to be brief, symptom severity frequently dictates initial treatment. Sometimes the fear that a symptom will worsen can be more crippling than the symptom itself, and reassurance that effective treatment is available may be all a patient needs. When a symptom is quite severe or the diagnostic alternatives do not affect treatment, the physician should quickly relieve suffering by treating the symptom.

Pain

About half of patients dying of cancer have severe pain. Yet, only half of these patients receive reliable pain relief. Many patients dying of organ system failure and dementia also have severe pain. Sometimes pain can be controlled but persists because patients, family members, and physicians have misconceptions about pain and the drugs (especially opioids) that can control it, resulting in significant underdosing.

Patients perceive pain differently, depending partly on whether other factors (eg, fatigue, insomnia, anxiety, depression, nausea) are present. Analgesic choice depends largely on pain intensity and cause, which can be determined only by talking with and observing patients. Patients and physicians must recognize that all pain can be relieved by an appropriately potent drug at sufficient dosage, although aggressive treatment may also cause sedation or confusion. Commonly used drugs are aspirin, acetaminophen, or NSAIDs for mild pain; oxycodone for moderate pain; and hydromorphone, morphine, or fentanyl for severe pain (see p. 1623).

In dying patients, oral opioid therapy is most convenient and cost-effective. Rectal opioid therapy provides more uneven absorption; however, 1st-pass effect is often minimal. Morphine suppositories or pills may be given rectally at the same dosage used for oral forms and then titrated as needed. IV or sc opioid therapy is better than IM injections, which are painful and result in variable absorption. Long-acting opioids are best for long-lasting pain. When giving opioids, the physician should prescribe them in adequate dosage and on a continuous basis to prevent pain. Unreasonable concerns by the public and by health care practitioners about addiction often tragically limit appropriate use of opioids. Pharmacologic dependence may result from regular use but causes no problems in dying patients except the need to avoid inadvertent withdrawal. Addictive behaviors are rare and usually easy to control.

Adverse effects of opioids include nausea, sedation, confusion, constipation, and respiratory depression. Constipation should be treated prophylactically (see p. 3486). Patients usually develop substantial tolerance to the respiratory depressant and sedative effects of morphine but have much less tolerance for the analgesic and constipating effects. Opioids may also cause myoclonus, agitated delirium, hyperalgesia, and seizures. These effects may result from accumulation of toxic metabolites and usually resolve when another opioid is substituted. Patients with these adverse effects and serious pain often warrant consultation with a palliative care specialist or pain specialist.

When a stable opioid dose becomes inadequate, increasing the dose by 1 1/2 to 2 times the previous dose is reasonable. Usually, serious respiratory depression does not occur unless the new dose is much more than twice the previously tolerated dose. Clinicians often are unfamiliar and thus uncomfortable with such large dosage increases. Increasing the dose over 1 to 2 h with constant observation and having opioid antagonists immediately available can overcome that reluctance.

Use of adjunctive drugs for pain control often increases comfort and reduces the opioid dosage and consequent adverse effects. Corticosteroids can reduce the pain of inflammation and swelling. Tricyclic antidepressants (eg, nortriptyline, doxepin) help manage neuropathic pain (see p. 1632); doxepin can provide bedtime sedation as well. Gabapentin 300 to 1200 mg po tid helps relieve neuropathic pain. Methadone is effective for refractory or neuropathic pain; however, its kinetics vary and it requires close monitoring. Benzodiazepines are useful for patients whose pain is worsened by anxiety.

For severe localized pain, regional nerve blocks given by an anesthesiologist experienced in pain management may provide relief with few adverse effects. Various nerve-blocking techniques may be used. Indwelling epidural or intrathecal catheters can provide continuous infusion of analgesics, often mixed with anesthetic drugs.

Pain-modification techniques (eg, guided mental imagery, hypnosis, acupuncture, relaxation, biofeedback) help some patients (see p. 3417). Counseling for stress and anxiety may be very helpful, as may spiritual support from a chaplain.

Dyspnea

Dyspnea is one of the most feared symptoms and is extremely frightening to dying patients.

Quickly reversible causes should be treated specifically. For example, placing a chest tube for tension pneumothorax or doing thoracentesis for a pleural effusion provides quick and definitive relief. However, if death is imminent or a definitive treatment for the cause of dyspnea is not available, proper symptomatic treatment assures patients they will be comfortable, regardless of the cause.

As a first intervention, O2 helps correct hypoxemia. Even when its oxygenating benefit is no longer certain, O2 may continue to be psychologically comforting to patients and family members. O2 therapy is most comfortable by nasal cannula, so this route is preferred unless higher concentrations are critically important.

Morphine 2 to 10 mg sublingually or 2 to 4 mg sc q 2 to 4 h prn helps reduce breathlessness in an opioid-naive patient. Such a low dosage of morphine may blunt the medullary response to CO2 retention or O2 decline, reducing dyspnea and decreasing anxiety without causing harmful respiratory depression. If patients are already taking opioids for pain, dosages that relieve dyspnea must often be more than double the patient's usual dosages.

Airway congestion is best managed with drugs that dry secretions (eg, topical scopolamine gel 0.25 to 0.5 mg q 8 to 12 h applied to the skin behind the ear or on the chest, hyoscyamine 0.125 mg sublingually q 8 h, diphenhydramine 10 to 50 mg IM q 4 to 6 h prn).

Nebulized saline may help patients with viscous secretions. Nebulized albuterol and oral or injectable corticosteroids may relieve bronchospasm and bronchial inflammation.

Benzodiazepines often help relieve anxiety associated with dyspnea and with the fear of a return of dyspnea. Useful nondrug measures include providing a cool draft from an open window or fan and maintaining a calming presence.

Anorexia

Anorexia and marked weight loss are common among dying patients. For family members, accepting the patient's poor oral intake is often difficult because it means accepting that the patient is dying. Patients should be offered their favorite foods whenever possible. Conditions that may cause poor intake and that can be easily treated¾gastritis, constipation, toothache, oral candidiasis, pain, and nausea¾should be treated. Some patients benefit from appetite stimulants such as oral corticosteroids (dexamethasone 2 to 8 mg bid or prednisone 10 to 30 mg once/day) or megestrol 160 to 480 mg po once/day. However, if a patient is close to death, family members should understand that neither food nor hydration is necessary to maintain the patient's comfort.

IV fluids, TPN, and tube feedings do not prolong the life of dying patients. All of these measures seem to increase discomfort and may hasten death. Pulmonary congestion and pneumonia are more common among dying patients who are fed artificially. Artificial hydration may worsen edema and pain associated with inflammation. Conversely, dehydration and ketosis due to caloric restriction correlate with analgesic effects and absence of discomfort. The only reported discomfort due to dehydration near death is xerostomia, which is easily relieved with oral swabs or ice chips.

Family members should be gently told that the patient is dying and that food does not help the patient's strength nor substantially delay death; they should be reassured that the patient does not suffer from having little or no intake. Having family members and friends take on specific tasks (eg, providing favorite foods, small portions, and foods that are easy to swallow) provides other ways to show caring and love, which can help family members.

Even debilitated and cachectic patients may live for several weeks with no food and minimal hydration. Family members should understand that stopping fluids does not result in the patient's immediate death and ordinarily does not hasten death. Supportive care, including good oral hygiene, is imperative for patient comfort during this time.

Nausea and Vomiting

Many seriously ill patients experience nausea, frequently without vomiting. Nausea may arise with GI problems (eg, constipation, gastritis), metabolic abnormalities (eg, hypercalcemia, uremia), drug adverse effects, increased intracranial pressure secondary to cerebral cancer, and psychosocial stress. When possible, treatment should match the likely cause¾eg, stopping NSAIDs, treating gastritis with H2 blockers, and trying corticosteroids for patients with known or suspected brain metastases. If nausea is due to gastric distention and reflux, metoclopramide (eg, 10 to 20 mg po or sc qid prn or given on a scheduled basis) is useful because it increases gastric tone and contractions while relaxing the pyloric sphincter.

Patients with no specific cause of nausea may benefit from treatment with a phenothiazine (eg, promethazine 25 mg po qid; prochlorperazine 10 mg po before meals or, for patients who cannot take oral drugs, 25 mg rectally bid). Anticholinergic drugs such as scopolamine and the antihistamines meclizine and diphenhydramine prevent recurrent nausea in many patients. Combining lower doses of the previously mentioned drugs often improves efficacy. Second-line drugs for intractable nausea include haloperidol (started at 1 mg po or sc q 6 to 8 h, then titrated to as much as 15 mg/day). The 5-HT3 antagonists ondansetron and granisetron often dramatically relieve chemotherapy-induced nausea. Cost often makes these antagonists 2nd-line drugs for more complex causes of nausea in dying patients.

Nausea and pain due to intestinal obstruction are common among patients with widespread abdominal cancer. Generally, IV fluids and nasogastric suction are more burdensome than useful. Symptoms of nausea, pain, and intestinal spasm respond to hyoscyamine (0.125 to 0.25 mg q 4 h sublingually or sc), scopolamine (1.5 mg topically), morphine (given sc or rectally), or any of the other previously mentioned antiemetics. Octreotide 150 mg sc or IV q 12 h inhibits GI secretions and dramatically reduces nausea and painful distention. Given with antiemetics, octreotide usually eliminates the need for nasogastric suctioning. Corticosteroids (eg, dexamethasone 4 to 6 mg IV, IM, or rectally tid) may decrease obstructive inflammation at the tumor site and temporarily relieve the obstruction. IV fluids may exacerbate obstructive edema.

Constipation

Constipation is common among dying patients because of inactivity, use of opioids and drugs with anticholinergic effects, and decreased intake of fluids and dietary fiber. Regular bowel movements are essential to the comfort of dying patients, at least until the last day or two of life. Laxatives help prevent fecal impaction, especially in patients receiving opioids. Monitoring bowel function regularly is essential. Most patients do well on a twice/day regimen of stool softener (eg, docusate) plus a mild stimulant laxative (eg, casanthranol, senna). If stimulant laxatives cause cramping discomfort, patients may respond to increased doses of docusate alone or an osmotic laxative, such as lactulose or sorbitol started at 15 to 30 mL po bid and titrated to effect.

Soft fecal impaction may be treated with a bisacodyl suppository or saline enema. For a hard fecal impaction, a mineral oil enema may be given, possibly with an oral benzodiazepine (eg, lorazepam) or an analgesic, followed by digital disimpaction. After disimpaction, patients should be placed on a more aggressive bowel regimen to avoid recurrence.

Pressure Ulcers

Many dying patients are immobile, poorly nourished, incontinent, and cachectic and thus are at risk of pressure ulcers (see also p. 736). Prevention requires relieving pressure by rotating the patient or shifting the patient's weight every 2 h; a specialized mattress or continuously inflated air-suspension bed may also help. Incontinent patients should be kept as dry as possible. Generally, use of an indwelling catheter, with its inconvenience and risk of infection, is justified only when bedding changes cause pain or when patients or family members strongly prefer it.

Confusion

Mental changes that can accompany the terminal stage of a disorder may distress patients and family members; however, patients are often unaware of them. Confusion (delirium) is common; causes include drugs, hypoxia, metabolic disturbances, and intrinsic CNS disorders. If the cause can be determined, simple treatment may enable patients to communicate more meaningfully with family members and friends. Patients who are comfortable and less aware of their surroundings may do better with no treatment. When possible, the physician should ascertain the preferences of patients and family members and use them to guide treatment.

Simple causes of confusion and agitation should be sought. Agitation and restlessness often result from urinary retention, which resolves promptly with urinary catheterization. Confusion in debilitated patients is worsened by sleep deprivation. Agitated patients may benefit from benzodiazepines; however, benzodiazepines may also cause confusion. Poorly controlled pain may cause insomnia or agitation. If pain has been appropriately controlled, a nighttime sedative may help.

Family members and visitors may help lessen confusion by frequently holding the patient's hand and repeating where the patient is and what is happening. Patients with severe terminal agitation resistant to other measures may respond best to barbiturates; family members should be made aware that when near death, patients do not usually wake up much after starting these drugs. Pentobarbital, a rapid-onset, short-acting barbiturate, may be given as 100 to 200 mg IM q 4 h prn. Phenobarbital, which is longer-acting, may be given po, sc, or rectally. Midazolam, a short-acting benzodiazepine, also is often effective.

Depression

Most dying patients experience some depressive symptoms. Providing psychologic support and allowing patients to express concerns and feelings are usually the best approach. A skilled social worker, physician, nurse, or chaplain can help with these concerns.

A trial of antidepressants is often appropriate for patients who have persistent, clinically significant depression. SSRIs are useful for patients likely to live beyond the 4 wk usually needed for onset of the antidepressant effect. Depressed patients with anxiety and insomnia may benefit from a sedating tricyclic antidepressant given at bedtime. For patients who are withdrawn or who have vegetative signs (see p. 1666), methylphenidate may be started at 2.5 mg po once/day and increased to 2.5 to 5 mg bid (given at breakfast and lunch) as necessary. Methylphenidate (same dosage) can provide a few days or weeks of increased energy for patients who are fatigued or somnolent because of analgesics. Methylphenidate has a rapid effect but may precipitate agitation. Although its duration of action is short, adverse effects are also short-lived.

Stress

A few people approach death peacefully, but more patients and family members experience stressful periods. Death is particularly stressful when interpersonal conflicts keep patients and family members from sharing their last moments together in peace. Such conflicts can lead to excessive guilt or inability to grieve in survivors and can cause anguish in patients. A family member who is caring for a dying relative at home may experience physical and emotional stress. Usually, stress in patients and family members responds to compassion, information, counseling, and sometimes brief psychotherapy. Community services may be available to help relieve care-giver burden. Sedatives should be used sparingly and briefly.

When a partner dies, the survivor may be overwhelmed by having to make decisions about legal or financial matters or household management. For an elderly couple, the death of one may reveal the survivor's cognitive impairment, for which the deceased partner had compensated. The clinical team should identify such high-risk situations so that they can mobilize the resources needed to prevent undue suffering and dysfunction.

Grief

Grieving is a normal process that usually begins before an anticipated death. For patients, grief often starts with denial caused by fears about loss of control, separation, suffering, an uncertain future, and loss of self. Traditionally, the stages after grief were thought to occur in the following order: denial, anger, bargaining, depression, and acceptance. However, the stages that patients go through and their order of occurrence vary. Members of the clinical team can help patients accept their prognosis by listening to their concerns, helping them understand that they can control important elements of their life, explaining how the disorder will worsen and how death will come, and assuring them that their physical symptoms will be controlled. If grief is still very severe or causes psychosis or suicidal ideation or if the patient has a previous severe mental disorder, referral for professional evaluation and grief counseling may be needed.

Family members may need support in expressing grief. Any clinical team member who has come to know the patient and family members can help them through this process and direct them to professional services if needed. Physicians and other clinical team members need to develop regular procedures that ensure follow-up of grieving family members.

 

All of the following statements regarding euthanasia or physician-assisted suicide are true EXCEPT:

Complete Quiz and View Results
You will be able to view all answers at the end of your quiz.

The correct answer is A. You answered E.

The answer is A. Voluntary active euthanasia is defined as intentionally administering medications or other interventions to cause the patient’s death with the patient’s informed consent. It is legal in Belgium and the Netherlands, but not the United States. Physician-assisted suicide is defined as a physician providing medications or other interventions to a patient with the understanding that the patient can use them to commit suicide. This practice is legal in Montana, Oregon, Vermont, and Washington State. Fewer than 10%–20% of terminally ill patients actually consider euthanasia and/or physician-assisted suicide for themselves. In the Netherlands and Oregon, >70% of patients using these interventions are dying of cancer; in Oregon, in 2013, just 1.2% of physician-assisted suicide cases involved patients with HIV/AIDS and 7.2% involved patients with amyotrophic lateral sclerosis. Pain is not a primary motivator for patients’ requests for or interest in euthanasia and/or physician-assisted suicide. Fewer than 25% of all patients in Oregon cite inadequate pain control as the reason for desiring physician-assisted suicide. Depression, hopelessness, and, more profoundly, concerns about loss of dignity or autonomy or being a burden on family members appear to be primary factors motivating a desire for euthanasia or physician-assisted suicide. Over 75% cite loss of autonomy or dignity and inability to engage in enjoyable activities as the reason for wanting physician-assisted suicide. About 40% cite being a burden on family.

 


Reference

1. http://www.nejm.org/doi/full/10.1056/NEJMra1108646?query=TOC#t=article

From a legal standpoint in many countries, an individual is considered dead when there is complete and irreversible cessation of brain function. Many individual cells and tissues in a legally dead individual remain viable for some time after death, however, and constitute a major source of organs for transplantation.

Study Question

A 72-year-old woman has stage IV ovarian cancer with diffuse peritoneal studding. She is developing increasing pain in her abdomen and is admitted to the hospital for pain control. She previously was treated with oxycodone 10 mg orally every 6 hours as needed. Upon admission, she is initiated on morphine intravenously via patient-controlled analgesia. During the first 48 hours of her hospitalization, she received an average daily dose of morphine of 90 mg and reports adequate pain control unless she is walking. What is the most appropriate opioid regimen for transitioning this patient to oral pain medication?

Favorite Table | Download (.pdf) | Print
Sustained-Release Morphine Immediate-Release Morphine
A. None 15 mg every 4 hours as needed
B. 45 mg twice daily 5 mg every 4 hours as needed
C. 45 mg twice daily 15 mg every 4 hours as needed
D. 90 mg twice daily 15 mg every 4 hours as needed
E. 90 mg three time daily 15 mg every 4 hours as needed
Next Question
You will be able to view all answers at the end of your quiz.

The correct answer is C. You answered B.

The answer is C.(Chap. 10) A primary goal of palliative care medicine is to control pain in patients who are terminally ill. Surveys have found that 36%–90% of individuals with advanced cancer have substantial pain, and an individualized treatment plan is necessary for each patient. For individuals with continuous pain, opioid analgesics should be administered on a scheduled basis around the clock at an interval based on the half-life of the medication chosen. Extended- release preparations are frequently used due to their longer half-lives. However, it is inappropriate to start immediately with an extended-release preparation. In this scenario, the patient was treated with a continuous intravenous infusion via patient-controlled analgesia for 48 hours to determine her baseline opioid needs. The average daily dose of morphine required was 90 mg. This total dose should be administered in divided doses two or three times daily (either 45 mg twice daily or 30 mg three times daily). In addition, an immediate-release preparation should be available for administration for breakthrough pain. The recommended dose of the immediate release preparation is 20% of the baseline dose. In this case, the dose would be 18 mg and could be given as either 15 or 20 mg four times daily as needed.

 

 

 

 

CARE DURING THE LAST HOURS

Most laypersons have limited experiences with the actual dying process and death. They frequently do not know what to expect of the final hours and afterward. The family and other caregivers must be prepared, especially if the plan is for the patient to die at home.

Patients in the last days of life typically experience extreme weakness and fatigue and become bedbound; this can lead to pressure sores. The issue of turning patients who are near the end of life, however, must be balanced against the potential discomfort that movement may cause. Patients stop eating and drinking with drying of mucosal membranes and dysphagia. Careful attention to oral swabbing, lubricants for lips, and use of artificial tears can provide a form of care to substitute for attempts at feeding the patient. With loss of the gag reflex and dysphagia, patients may also experience accumulation of oral secretions, producing noises during respiration sometimes called “the death rattle.” Scopolamine can reduce the secretions. Patients also experience changes in respiration with periods of apnea or Cheyne-Stokes breathing. Decreased intravascular volume and cardiac output cause tachycardia, hypotension, peripheral coolness, and livedo reticularis (skin mottling). Patients can have urinary and, less frequently, fecal incontinence. Changes in consciousness and neurologic function generally lead to two different paths to death.

Each of these terminal changes can cause patients and families distress, requiring reassurance and targeted interventions (Table 12-9). Informing families that these changes might occur and providing them with an information sheet can help preempt problems and minimize distress. Understanding that patients stop eating because they are dying, not dying because they have stopped eating, can reduce family and caregiver anxiety. Similarly, informing the family and caregivers that the “death rattle” may occur and that it is not indicative of suffocation, choking, or pain can reduce their worry from the breathing sounds.

TABLE 12-9Managing Changes in the Patient’s Condition during the Final Days and Hours
View Table| |Download (.pdf)

Families and caregivers may also feel guilty about stopping treatments, fearing that they are “killing” the patient. This may lead to demands for interventions, such as feeding tubes, that may be ineffective. In such cases, the physician should remind the family and caregivers about the inevitability of events and the palliative goals. Interventions may prolong the dying process and cause discomfort. Physicians also should emphasize that withholding treatments is both legal and ethical and that the family members are not the cause of the patient’s death. This reassurance may have to be provided multiple times.

Hearing and touch are said to be the last senses to stop functioning. Whether this is the case or not, families and caregivers can be encouraged to communicate with the dying patient. Encouraging them to talk directly to the patient, even if he or she is unconscious, and hold the patient’s hand or demonstrate affection in other ways can be an effective way to channel their urge “to do something” for the patient.

When the plan is for the patient to die at home, the physician must inform the family and caregivers how to determine that the patient has died. The cardinal signs are cessation of cardiac function and respiration; the pupils become fixed; the body becomes cool; muscles relax; and incontinence may occur. Remind the family and caregivers that the eyes may remain open even after the patient has died.

The physician should establish a plan for who the family or caregivers will contact when the patient is dying or has died. Without a plan, family members may panic and call 911, unleashing a cascade of unwanted events, from arrival of emergency personnel and resuscitation to hospital admission. The family and caregivers should be instructed to contact the hospice (if one is involved), the covering physician, or the on-call member of the palliative care team. They should also be told that the medical examiner need not be called unless the state requires it for all deaths. Unless foul play is suspected, the health care team need not contact the medical examiner either.

Just after the patient dies, even the best-prepared family may experience shock and loss and be emotionally distraught. They need time to assimilate the event and be comforted. Health care providers are likely to find it meaningful to write a bereavement card or letter to the family. The purpose is to communicate about the patient, perhaps emphasizing the patient’s virtues and the honor it was to care for the patient, and to express concern for the family’s hardship. Some physicians attend the funerals of their patients. Although this is beyond any medical obligation, the presence of the physician can be a source of support to the grieving family and provides an opportunity for closure for the physician.

Death of a spouse is a strong predictor of poor health, and even mortality, for the surviving spouse. It may be important to alert the spouse’s physician about the death so that he or she is aware of symptoms that might require professional attention.